Physician profile
Andrew Mcdonald
NPI 1972618775
$685.65
in general payments reported to CMS, 2019-2025
14 companies · $330 in 2025
The $330 reported for 2025 was more than what 89% of Sports Medicine (Pediatrics) providers received nationally (typical 2025 total: $59.86).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.92 · 2022: $59.38 · 2023: $54.60 · 2024: $177 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrocision, INC. | $130.08 | 2025 | Tenjet |
| Janssen Pharmaceuticals, INC | $123.56 | 2022-2024 | Xarelto |
| Ferring Pharmaceuticals INC. | $111.19 | 2019-2023 | Euflexxa |
| Abbvie INC. | $105.64 | 2023-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $31.84 | 2025 | Caplyta |
| Dexcom, INC. | $30.45 | 2025 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $30.29 | 2025 | Watchman Flx |
| Alexion Pharmaceuticals, INC. | $22.15 | 2025 | Koselugo |
| Eisai INC. | $19.69 | 2024 | |
| Phathom Pharmaceuticals, INC. | $19.22 | 2024 | Voquezna |
| Novo Nordisk INC | $17.71 | 2025 | |
| Lilly USA, LLC | $15.67 | 2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $14.59 | 2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $13.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Mcdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.